Capital International Inc’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,213
Closed -$864K 333
2023
Q4
$864K Buy
29,213
+2,520
+9% +$52.3K 0.01% 300
2023
Q3
$554K Buy
26,693
+3,065
+13% +$84.2K 0.01% 298
2023
Q2
$580K Hold
23,628
0.01% 306
2023
Q1
$960K Hold
23,628
0.02% 257
2022
Q4
$1.06M Buy
23,628
+4,184
+22% +$189K 0.02% 255
2022
Q3
$930K Sell
19,444
-3,854
-17% -$211K 0.02% 262
2022
Q2
$1.38M Sell
23,298
-290
-1% -$23.8K 0.02% 238
2022
Q1
$2.74M Sell
23,588
-24,273
-51% -$2.83M 0.03% 217
2021
Q4
$7.2M Buy
47,861
+3,293
+7% +$444K 0.07% 183
2021
Q3
$5.32M Sell
44,568
-3,579
-7% -$394K 0.05% 196
2021
Q2
$4.69M Sell
48,147
-1,541
-3% -$137K 0.04% 210
2021
Q1
$4.38M Sell
49,688
-942
-2% -$87.5K 0.04% 209
2020
Q4
$4.84M Buy
50,630
+30,525
+152% +$3.15M 0.04% 197
2020
Q3
$2.28M Buy
+20,105
New +$2.11M 0.03% 221

Other funds holding TNDM

Capital International Inc's TNDM Position: Q1 2024 in Review

Capital International Inc sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 29,213 shares — an estimated $864K sold.

Capital International Inc first reported a position in TNDM in Q3 2020 and held it in 14 quarters. The position peaked at $7.2M in Q4 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Capital International Inc reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • Capital International Inc sold 29,213 Tandem Diabetes Care shares in Q1 2024, an estimated $864K.
  • Capital International Inc first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 14 quarters.
  • Capital International Inc's Tandem Diabetes Care position peaked at $7.2M in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Capital International Inc's 13F filing for Q1 2024, filed 14 May 2024.